Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of the Incidence of Expression of Tumor Antigens in Cancer Tissue From Patients With Pathologically Demonstrated Bladder Cancer

NCT01706185 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01706185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01706185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of the Incidence of Expression of Tumor Antigens in Cancer Tissue From Patients With Pathologically Demonstrated Bladder Cancer
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
January 15, 2008
Completion date
January 15, 2008
Enrollment
156 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms, urinary bladder